BCRX BioCryst Pharmaceuticals
- 7.030
- -0.420-5.64%
BioCryst Pharmaceuticals News
BioCryst Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
BioCryst Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
BioCryst Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
BioCryst Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
BioCryst Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
BioCryst Pharmaceuticals | 424B5: Prospectus
BioCryst Pharmaceuticals | 424B2: Prospectus
BioCryst Pharmaceuticals | 424B5: Prospectus
BioCryst Pharmaceuticals | EFFECT: Others
BioCryst Pharmaceuticals | 424B5: Prospectus
BioCryst Pharmaceuticals | 424B2: Prospectus
BioCryst Pharmaceuticals | 424B5: Prospectus
BioCryst Pharmaceuticals | 424B2: Prospectus
BioCryst Pharmaceuticals | 424B5: Prospectus
BioCryst Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
BioCryst Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
BioCryst Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
BioCryst Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
BioCryst Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
BioCryst Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Analysis
Price Target
No Data
No Data